Debra L. Taylor

Mill Hill
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Identification of a novel specific small-molecule melanocortin-2-receptor antagonist.

Identification of a novel specific small-molecule melanocortin-2-receptor antagonist.

Journal: Endocrine connections

Published: September 28, 2022

Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.

Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.

Journal: Frontiers in immunology

Published: July 01, 2020

Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) - Part 1.

Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) - Part 1.

Journal: Bioorganic & medicinal chemistry letters

Published: August 16, 2018

Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3.

Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3.

Journal: Cellular and molecular life sciences : CMLS

Published: July 14, 2016

ACTH Antagonists.

ACTH Antagonists.

Journal: Frontiers in endocrinology

Published: May 23, 2016

Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES.

Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES.

Journal: The Journal of biological chemistry

Published: December 16, 2015

Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.

Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.

Journal: Antimicrobial agents and chemotherapy

Published: July 30, 2014

Optimization of an imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).

Optimization of an imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).

Journal: Journal of medicinal chemistry

Published: April 03, 2014

Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues.

Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues.

Journal: Bioorganic & medicinal chemistry letters

Published: June 18, 2013

Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.

Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.

Journal: Journal of biomolecular screening

Published: February 12, 2013

High-throughput identification and characterization of novel, species-selective GPR35 agonists.

High-throughput identification and characterization of novel, species-selective GPR35 agonists.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 25, 2012

Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).

Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).

Journal: Bioorganic & medicinal chemistry letters

Published: December 12, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026